Central Neurodegenerative Diseases

Zevra Therapeutics has announced that Miplyffa, the first Nieman-Pick disease type C treatment approved by the FDA, is commercially available.

WASHINGTON — Patients with glaucoma may have an increased prevalence of certain central neurodegenerative diseases, such as various types of non-Alzheimer’s dementia, according to a speaker here.